AMH and polycystic ovary syndrome: Evidence for this second mechanism is that gestational exposure of mice to recombinant AMH during a critical gestational age induces maternal neuroendocrine-driven hyperandrogenism and diminishes placental aromatization, causing a PCOS-like phenotype in female offspring and their descendants over multiple generations [90, 98].